2024
Immune checkpoint inhibitors in high‐grade upper tract urothelial carcinoma: Paradigm shift emphasizing organ preservation
Khalil M, Fishman A, Komorowski A, Franco I, Grasso M. Immune checkpoint inhibitors in high‐grade upper tract urothelial carcinoma: Paradigm shift emphasizing organ preservation. BJUI Compass 2024, 5: 490-496. PMID: 38751949, PMCID: PMC11090768, DOI: 10.1002/bco2.335.Peer-Reviewed Original ResearchImmune check point inhibitorsHigh-grade upper tract urothelial carcinomaUpper tract urothelial carcinomaMetastasis-free survival ratesGroup 2Group 1Survival rateUrothelial carcinomaSurvival outcomesMedian follow-up periodImpact of clinical characteristicsCheck-point inhibitorsImmune checkpoint inhibitorsEndoscopically treated patientsInitial tumor sizeImprove survival outcomesOverall survival rateKaplan-Meier analysisFollow-up periodImproved survival ratesCheckpoint inhibitorsPoint inhibitorsExtirpative surgeryTumor sizeClinical characteristics
2001
A multi‐institutional analysis of laparoscopic orchidopexy
Baker L, Docimo S, Surer I, Peters C, Cisek L, Diamond D, Caldamone A, Koyle M, Strand W, Moore R, Mevorach R, Brady J, Jordan G, Erhard M, Franco I. A multi‐institutional analysis of laparoscopic orchidopexy. BJU International 2001, 87: 484-489. PMID: 11298039, DOI: 10.1046/j.1464-410x.2001.00127.x.Peer-Reviewed Original ResearchConceptsLaparoscopic orchidopexyGroup 1Small seriesAtrophy ratesImpalpable testesOpen approachSuccess rateImpalpable undescended testicleOne-stage FowlerMulti-institutional analysisProcedure of choiceTwo-stage repairHigher atrophy ratesIntra-abdominal testesLack of atrophyTwo-stage FSatisfactory scrotal positionIntrascrotal positionUnrandomized studyClinical chartsSurgical groupLaparoscopic approachLaparoscopic examinationTherapeutic laparoscopyUndescended testicle